Andy Bader

Company: Triumvira Immunologics

Job title: CSO

Seminars:

TAC-T Cells for Solid Tumors 3:30 pm

Key advantages of T cells engineered with the TAC (T Cell Antigen Coupler) receptor to treat solid tumors Development status of TAC01-HER2, a HER2-directed TAC-T cell product in a Phase I clinical trial Identification and development of novel TAC receptors against safe solid tumor antigensRead more

day: Day One